The ingredient industry is rapidly growing, fueled by demand for natural food, cosmetics, and innovative products using plant extracts, probiotics, and algae extracts. However, proteins from foreign species may trigger immune responses, leading to allergic sensitization.
PHYLOGENE specializes in advanced allergen risk assessment, combining cutting-edge technologies with expertise. Using high-resolution nano LC-MS/MS proteomics, PHYLOGENE identifies allergenic peptides through homology analysis with known allergens and evaluates neoallergen risks.
Their proprietary CORAVALID™ process assesses sensitization potential on cell lines like dendritic cells and keratinocytes. Additionally, PHYLOGENE offers quantitative inhibition of allergen-specific IgE antibodies (ELISA), providing comprehensive, regulatory-compliant solutions for allergen safety in complex ingredient mixtures.
Gilbert Skorski
PHYLOGENE
62, Route Nationale 113
30620 BERNIS
Tel : +33 4 66 04 77 99
Fax : +33 4 66 04 77 97
e-mail : gskorski@phylogene.com
web : www.phylogene.com
LinkedIn : https://www.linkedin.com/company/phylogene
Twitter : https://twitter.com/Phylogene_One
Special Webinar: Thursday, 27 March 2025 at 3 p.m. Cosmetic active ingredients and products are…
Editor Tim Probert caught up with four participants - Anne Charpentier, CEO of Skinobs; Mike…
Mieke Meintjes 27 February 2025 Scientists at Florida International University and the University of Miami,…